AudioCure Pharma's AC102 receives EMA orphan drug designation for the treatment of sudden sensorineural hearing loss (SSNHL) - Business Wire https://t.co/eAhT9FgMHU
— IDRO (@IDROOhio) January 30, 2019
from Twitter https://twitter.com/IDROOhio
January 29, 2019 at 10:05PM
No comments:
Post a Comment